Merck & Co., in the Whitehouse Station section of Readington, announced today the appointment of Dr. Roger M. Perlmutter as president of Merck Research Laboratories, effective April 15.
According to an announcement from Merck, Perlmutter will succeed Peter S. Kim, who has served in the role since 2003. Perlmutter was executive vice president and head of R&D at Amgen Inc. from January 2001 to February 2012. Prior to joining Amgen, he was executive vice president of worldwide basic research and preclinical development at Merck. He joined Merck as a senior vice president in February 1997.